Citations as recorded by:

1. Conventional drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma

World J Hepatol, 2017, 9 p. 808

DOI: 10.4254/wjh.v9.i18.808

Citations as recorded by: PMC

2. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study

Acta Radiol, 2017, 58(2) p. 131

DOI: 10.1177/0284185116648501

Citations as recorded by: Cross Ref

3. Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis

Clinics and Research in Hepatology and Gastroenterology, 2017, 41(1) p. 75

DOI: 10.1016/j.clinre.2016.05.013

Citations as recorded by: Cross Ref

4. Dexamethasone Prophylaxis to Alleviate Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Study

Journal of Vascular and Interventional Radiology, 2017, 28(11) p. 1503

DOI: 10.1016/j.jvir.2017.07.021

Citations as recorded by: Cross Ref

5. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma

Eur Radiol, 2017, 27(5) p. 2031

DOI: 10.1007/s00330-016-4548-3

Citations as recorded by: Cross Ref Google

6. Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model

Eur Radiol,

DOI: 10.1007/s00330-017-4856-2

Citations as recorded by: Cross Ref

7. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional …

Year: 2017

Citations as recorded by: Google

8. Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic …

Year: 2017

Citations as recorded by: Google

9. A prototype of injector to control and to detect the release of magnetic beads within the constraints of multibifurcation magnetic resonance navigation procedures

Year: 2017

Citations as recorded by: Google

10. Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as …

Year: 2017

Citations as recorded by: Google

11. 肝細胞癌に対する TACE: 最近の話題

Year: 2017

Citations as recorded by: Google

12. Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma

Onco Targets Ther, 2016, 9 p. 7029

DOI: 10.2147/OTT.S112555

Citations as recorded by: PMC

13. Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma.

Onco Targets Ther, 2016, 9 p. 7

Citations as recorded by: Google

14. Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison

Oncotarget, 2016, 8 p. 15101

DOI: 10.18632/oncotarget.13145

Citations as recorded by: PMC Google

15. A mixed analysis comparing nine minimally invasive surgeries for unresectable hepatocellular carcinoma patients

Oncotarget, 2016, 8 p. 5460

DOI: 10.18632/oncotarget.12348

Citations as recorded by: PMC

16. Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma

Digestive and Liver Disease, 2016, 48(7) p. 798

DOI: 10.1016/j.dld.2016.03.031

Citations as recorded by: Cross Ref Google

17. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis

Digestive and Liver Disease, 2016, 48(6) p. 571

DOI: 10.1016/j.dld.2016.02.005

Citations as recorded by: Cross Ref Google

18. Pharmacodynamics study of zedoary turmeric oil chitosan microspheres administered via arterial embolization

Artificial Cells, Nanomedicine, and Biotechnology, 2016, 44(8) p. 1958

DOI: 10.3109/21691401.2015.1115411

Citations as recorded by: Cross Ref Google

19. Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels

J Clin Transl Hepatol, 2016, 4 p. 288

DOI: 10.14218/JCTH.2016.00058

Citations as recorded by: PMC Google

20. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases

Journal of Vascular and Interventional Radiology, 2016, 27(9) p. 1298

DOI: 10.1016/j.jvir.2016.05.014

Citations as recorded by: Cross Ref Google

21. Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis

Med Sci Monit, 2016, 22 p. 1773

DOI: 10.12659/MSM.895548

Citations as recorded by: Cross Ref PMC

22. Efficacy and safety of cTACEversusDEB-TACE in patients with hepatocellular carcinoma: a meta-analysis

Journal of Digestive Diseases, 2016, 17(8) p. 510

DOI: 10.1111/1751-2980.12380

Citations as recorded by: Cross Ref

23. Efficacy and safety of cTACE versus DEB‐TACE in patients with hepatocellular carcinoma: a meta‐analysis

Year: 2016

Citations as recorded by: Google

24. Improvement of survival rate for patients with hepatocellular carcinoma using transarterial chemoembolization in combination with three-dimensional …

Year: 2016

Citations as recorded by: Google

25. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients

World J Hepatol, 2015, 7 p. 2009

DOI: 10.4254/wjh.v7.i16.2009

Citations as recorded by: PMC Google

26. Target patients for partial hepatectomy and relationship between PLT and prognosis in BCLC B HCC

Journal of Hepatology, 2015, 62(3) p. 750

DOI: 10.1016/j.jhep.2014.11.006

Citations as recorded by: Cross Ref Google

27. Quimioembolización transarterial con partículas liberadoras de doxorrubicina frente a quimioembolización transarterial convencional en carcinomas hepatocelulares irresecables: un estudio de eficacia, seguridad y gastos

Radiología, 2015, 57(6) p. 496

DOI: 10.1016/j.rx.2015.01.008

Citations as recorded by: Cross Ref

28. Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs

Radiología (English Edition), 2015, 57(6) p. 496

DOI: 10.1016/j.rxeng.2015.09.004

Citations as recorded by: Cross Ref

29. Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma

Hepatol Res, 2015, 45(2) p. 190

DOI: 10.1111/hepr.12450

Citations as recorded by: Cross Ref

30. HEPATOCELIULINĖS KARCINOMOS GYDYMO TRANSARTERINE CHEMOEMBOLIZACIJA DOKSORUBICINU IMPREGNUOTOMIS MIKROSFEROMIS (DEB TACE) LIETUVOS SVEIKATOS MOKSLŲ UNIVERSITETO LIGONINĖJE KAUNO KLINIKOSE ANALIZĖ

21(4.1) p. 559

DOI: 10.15591/mtp.2015.087

Citations as recorded by: Cross Ref

31. Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma

Saudi J Gastroenterol, 2015, 21 p. 175

DOI: 10.4103/1319-3767.157571

Citations as recorded by: PMC Google

32. Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations

HPB, 2015, 17(1) p. 52

DOI: 10.1111/hpb.12273

Citations as recorded by: Cross Ref PMC Google

33. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

BMC Cancer, 2015, 15(1)

DOI: 10.1186/s12885-015-1480-x

Citations as recorded by: Cross Ref PMC Google

34. Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: a …

Year: 2015

Citations as recorded by: Google

35. Does Drug-Eluting Bead Transcatheter Arterial Chemoembolization Improve the Management of Patients with Hepatocellular Carcinoma? A Meta-Analysis

PLoS ONE, 2014, 9(8) p. e102686

DOI: 10.1371/journal.pone.0102686

Citations as recorded by: Cross Ref PMC Google

36. Doxorubicin-eluting beads versus conventional transarterialchemoembolization for the treatment of hepatocellular carcinoma: a meta-analysis

Int J Clin Exp Med, 2014, 7 p. 3892

Citations as recorded by: PMC Google

37. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques

World J Hepatol, 2014, 6 p. 844

DOI: 10.4254/wjh.v6.i12.844

Citations as recorded by: PMC Google

38. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma

J Gastroenterol Hepatol, 2014, 29(5) p. 920

DOI: 10.1111/jgh.12439

Citations as recorded by: Cross Ref

39. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.

J. Gastroenterol. Hepatol., 2014, 29 p. 9

DOI: 1

Citations as recorded by: Google

40. IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma

Med Sci Monit, 2014, 20 p. 247

DOI: 10.12659/MSM.889891

Citations as recorded by: Cross Ref PMC

41. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review

Year: 2014

Citations as recorded by: Google

42. Transarterial Chemoembolization–Status Quo in Germany

Year: 2013

Citations as recorded by: Google

43. The clinical value of MRI using single-shot echoplanar DWI to identify liver involvement in patients with advanced gastroenteropancreatic-neuroendocrine tumors (GEP-NETs), compared to FSE T2 and FFE T1 weighted image after i.v. Gd-EOB-DTPA contrast enhancement

Med Sci Monit, 2012, 18(5) p. MT33

DOI: 10.12659/MSM.882719

Citations as recorded by: Cross Ref PMC

44. Thermal ablation of unresectable liver tumors: Factors associated with partial ablation and the impact on long-term survival

Med Sci Monit, 2012, 18(2) p. CR88

DOI: 10.12659/MSM.882463

Citations as recorded by: Cross Ref PMC Google

45. The clinical value of MRI using single-shot echoplanar DWI to identify liver involvement in patients with advanced gastroenteropancreatic-neuroendocrine …

Year: 2012

Citations as recorded by: Google